|
Volumn 57, Issue 2, 2001, Pages 301-305
|
A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction
a,c a b
c
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
PROSTAGLANDIN E1;
ADULT;
AGED;
AMBULATORY CARE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
ERECTILE DYSFUNCTION;
ERYTHEMA;
GEL;
HUMAN;
MALE;
PENIS GLANS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEXUAL BEHAVIOR;
SKIN TEMPERATURE;
SKIN TINGLING;
TACTILE STIMULATION;
ADMINISTRATION, CUTANEOUS;
ADULT;
AGED;
ALPROSTADIL;
DOUBLE-BLIND METHOD;
ERYTHEMA;
GELS;
HUMANS;
IMPOTENCE;
MALE;
MIDDLE AGED;
OFFICE VISITS;
PLACEBOS;
TREATMENT OUTCOME;
VASODILATOR AGENTS;
|
EID: 0035123243
PISSN: 00904295
EISSN: None
Source Type: Journal
DOI: 10.1016/S0090-4295(00)00936-5 Document Type: Article |
Times cited : (59)
|
References (22)
|